Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$23,899,844
+$6,154,722 QoQ
Shares Held
19,926
+3.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#823
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIERRA SUMMIT ADVISORS LLC holds $37,799,152 across 6 Drug Manufacturers - General names. LLY ranks #1 (63.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
19,926 | $23,899,844 | |
| 2 | ABBV |
AbbVie Inc.
|
17,459 | $4,393,382 | |
| 3 | JNJ |
Johnson & Johnson
|
15,509 | $3,938,820 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,917 | $2,816,334 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,647 | $1,420,160 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,532 | $1,330,612 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,899,844 | 19,926 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $17,745,122 | 19,293 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $16,712,350 | 15,551 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,672,960 | 17,920 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,665,803 | 16,248 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,559,908 | 11,575 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,380,832 | 10,856 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,052,308 | 9,089 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,056,976 | 8,899 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,488,186 | 8,340 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,726,024 | 6,392 | Shares | Sole | 2024-02-22 | |
| No filing history on record for this holder in this stock. | ||||||